Area of research
Infectious Diseases · Neurology
Research interest
Research interests include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, and Antibiotic Use and Resistance.
Cloxacillin versus cefazolin for meticillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): a prospective, open-label, multicentre, non-inferiority, randomised clinical trial
Clinical Characterization and Outcomes of Human Clade IIb Mpox Virus Disease: A European Multicenter Mpox Observational Cohort Study (MOSAIC).
Complex mpox situation, 2024.
Endemic avian influenza landscape in Asia: sustained zoonotic risks
From neglected to notoriety: a review of Mpox clinical features, virology, epidemiology, treatment and prevention strategies.
Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients
β-Lactam Inoculum Effect in Methicillin-Susceptible <i>Staphylococcus aureus</i> Infective Endocarditis
Implementation of a Clinical Decision Support System for Antimicrobial Prescribing in Sub-Saharan Africa: Multisectoral Qualitative Study
Implementation of a Clinical Decision Support System for Antimicrobial Prescribing in Sub-Saharan Africa: Multisectoral Qualitative Study.
Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study
A Healthcare-Associated Infection With Monkeypox Virus of a Healthcare Worker During the 2022 Outbreak
Clinical Decision Support Systems for Antibiotic Prescribing: An Inventory of Current French Language Tools
Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial
Viral epidemiology and SARS‐CoV‐2 co‐infections with other respiratory viruses during the first COVID‐19 wave in Paris, France
A Self-Assessment Web-Based App to Assess Trends of the COVID-19 Pandemic in France: Observational Study.
Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study.
Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study (Preprint)
Clinical decision support systems for antibiotic prescribing: an inventory of current French-language tools (Preprint)
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
Clinical and virological data of the first cases of COVID-19 in Europe: a case series
Type 1 interferons as a potential treatment against COVID-19
Type 1 interferons as a potential treatment against COVID-19.
Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?